More broadly, our analysis reveals discordant engagement of Smad4’s tumor-suppressive versus tumor-promoting effectors in liver versus lung metastases, demonstrating that the anatomic site of the tumor can uncouple TGFβ’s antitumorigenic and protumorigenic programs. This evidence concerns the gene SMAD4 and neoplasm.